From formulation to patient: Challenges in the development of clinically applicable lipid nanoparticles
Lipid nanoparticles (LNPs) are among the few nanotechnology platforms that have successfully transitioned from the labora tory to the clinic, as demonstrated by their use in mRNA vaccines against COVID-19 and in treatments for hereditary liver diseases. This review aimed to critically examine the literature from 2020-2...